Suzanne Morgan

Executive Director & Head of Market Access Stealth BioTherapeutics

Suzanne Morgan, PhD, MBA, is an Executive Director and Head of Market Access with more than 30 years of leadership experience across the pharmaceutical and biotechnology industries. She is recognized for her expertise in market access strategy, payer engagement, patient access solutions, and commercialization planning for emerging and established healthcare organizations. Suzanne brings a unique perspective at the intersection of academic research and real-world corporate complexity, translating evidence-based principles into practical strategies that drive organizational performance and patient access. Throughout her career, she has led cross-functional teams, developed innovative access programs, and partnered with stakeholders across the healthcare ecosystem to improve healthcare delivery. A respected industry leader and speaker, Suzanne is passionate about authentic leadership, developing high-performing teams, and advancing patient-centered healthcare through strategic innovation and collaboration.

Seminars

Thursday 29th October 2026
From Linked Data to Lost Decisions: Why Integrated RWD Still Fails at Payer Review
2:00 pm
  • Examining why technically strong real-world datasets and evidence still fail to translate into payer approval and real patient access
  • Identifying where data integration improves insight but does not address payer concerns, operational barriers, or patient access challenges
  • Aligning evidence strategies with how access decisions are made and implemented, including patient pathways, support programs, and real-world constraint
Suzanne Morgan